The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHDNEW YORK, July 07, 2026 (GLOBE NEWSWIRE) ...
The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHD NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharm ...
Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
We want to hear your thoughts on the PC brands you use (or manage) in a professional capacity. Take the survey for a chance ...
Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...
Morning Overview on MSN
A Moderna mRNA flu shot won a unanimous FDA panel nod for older adults
Older adults who face the highest rates of flu hospitalization moved one step closer to a new vaccine option on June 18, 2026 ...
Support vector regression can predict numeric values effectively, and this article shows how to implement and train a kernel SVR model in C# using stochastic sub-gradient descent.
LLMs are stuck in a groupthink groove. This startup is trying to get them out. Open up your chatbot of choice—Claude, ChatGPT ...
Interesting Engineering on MSN
US Navy tests 3D-printed composite patches to speed up F/A-18 fighter jet repairs
The Naval Air Warfare Center Aircraft Division (NAWCAD) and Fleet Readiness Center Southwest (FRCSW) ...
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results